Search research articles
Contact Us
Filters
Showing results (21-30 of 101) with videos related to
Page
of 11
Sort By:
Mitochondrion
|
December 21, 2010
Hypoxic and hypercapnic challenges unveil respiratory vulnerability of Surf1 knockout mice, an animal model of Leigh syndrome
Georg M Stettner, Carlo Viscomi, Massimo Zeviani, et al.
The Journal of Biological Chemistry
|
August 5, 2004
Interaction of the pacemaker channel HCN1 with filamin A
Biagio Gravante, Andrea Barbuti, Raffaella Milanesi, et al.
Nature Reviews. Drug Discovery
|
April 27, 2023
Opportunities for mitochondrial disease gene therapy
Carlo Viscomi, Jelle van den Ameele, Kathrin C Meyer, et al.
Molecular Therapy. Methods & Clinical Development
|
June 2, 2020
A Single Intravenous Injection of AAV-PHP.B-<i>hNDUFS4</i> Ameliorates the Phenotype of <i>Ndufs4</i> <sup></sup> Mice
Pedro Silva-Pinheiro, Raffaele Cerutti, Marta Luna-Sanchez, et al.
European Journal of Neurology
|
June 1, 2026
Letter to the Editor: Gastrointestinal Pseudo-Obstruction Is Not an Uncommon Phenotypic Manifestation of POLG1 Variants-Authors' Reply
Giuliana Capece, Renzo Manara, Leonardo Salviati, et al.
EMBO Molecular Medicine
|
August 21, 2012
Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy
Ivano Di Meo, Alberto Auricchio, Costanza Lamperti, et al.
Bioscience Reports
|
June 27, 2013
Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications
Tatjana M Hildebrandt, Ivano Di Meo, Massimo Zeviani, et al.
Antioxidants & Redox Signaling
|
September 4, 2010
Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy
Ivano Di Meo, Gigliola Fagiolari, Alessandro Prelle, et al.
Nature Reviews. Neurology
|
October 18, 2022
Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
Micol Falabella, Michal Minczuk, Michael G Hanna, et al.
Human Molecular Genetics
|
January 7, 2009
Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence
Daniele Ghezzi, Carlo Viscomi, Alessandra Ferlini, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 101) with videos related to
Sort By:
Page
of 11
Mitochondrion
|
December 21, 2010
Hypoxic and hypercapnic challenges unveil respiratory vulnerability of Surf1 knockout mice, an animal model of Leigh syndrome
Georg M Stettner, Carlo Viscomi, Massimo Zeviani, et al.
The Journal of Biological Chemistry
|
August 5, 2004
Interaction of the pacemaker channel HCN1 with filamin A
Biagio Gravante, Andrea Barbuti, Raffaella Milanesi, et al.
Nature Reviews. Drug Discovery
|
April 27, 2023
Opportunities for mitochondrial disease gene therapy
Carlo Viscomi, Jelle van den Ameele, Kathrin C Meyer, et al.
Molecular Therapy. Methods & Clinical Development
|
June 2, 2020
A Single Intravenous Injection of AAV-PHP.B-<i>hNDUFS4</i> Ameliorates the Phenotype of <i>Ndufs4</i> <sup></sup> Mice
Pedro Silva-Pinheiro, Raffaele Cerutti, Marta Luna-Sanchez, et al.
European Journal of Neurology
|
June 1, 2026
Letter to the Editor: Gastrointestinal Pseudo-Obstruction Is Not an Uncommon Phenotypic Manifestation of POLG1 Variants-Authors' Reply
Giuliana Capece, Renzo Manara, Leonardo Salviati, et al.
EMBO Molecular Medicine
|
August 21, 2012
Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy
Ivano Di Meo, Alberto Auricchio, Costanza Lamperti, et al.
Bioscience Reports
|
June 27, 2013
Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications
Tatjana M Hildebrandt, Ivano Di Meo, Massimo Zeviani, et al.
Antioxidants & Redox Signaling
|
September 4, 2010
Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy
Ivano Di Meo, Gigliola Fagiolari, Alessandro Prelle, et al.
Nature Reviews. Neurology
|
October 18, 2022
Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
Micol Falabella, Michal Minczuk, Michael G Hanna, et al.
Human Molecular Genetics
|
January 7, 2009
Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence
Daniele Ghezzi, Carlo Viscomi, Alessandra Ferlini, et al.
Page
of 11